TD Asset Management
ITCI

TD Asset Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

TD Asset Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-72,648
Closed -$5.2M – 1446
2023
Q4 		$5.2M Buy
+72,648
New +$4.18M 0.01% 756
2020
Q4 		– Sell
-16,916
Closed -$434K – 1484
2020
Q3 		$434K Sell
16,916
-6,412
-27% -$146K ﹤0.01% 1271
2020
Q2 		$599K Sell
23,328
-12,400
-35% -$251K ﹤0.01% 1181
2020
Q1 		$549K Buy
35,728
+5,728
+19% +$124K ﹤0.01% 1157
2019
Q4 		$1.03M Buy
+30,000
New +$360K ﹤0.01% 1085
2019
Q3 		– Sell
-14,900
Closed -$193K – 1374
2019
Q2 		$193K Buy
14,900
+700
+5% +$8.98K ﹤0.01% 1300
2019
Q1 		$173K Hold
14,200
– – ﹤0.01% 1313
2018
Q4 		$162K Sell
14,200
-6,900
-33% -$111K ﹤0.01% 1362
2018
Q3 		$458K Sell
21,100
-16,600
-44% -$347K ﹤0.01% 1308
2018
Q2 		$666K Sell
37,700
-11,400
-23% -$231K ﹤0.01% 1210
2018
Q1 		$1.03M Buy
+49,100
New +$956K ﹤0.01% 1051
2017
Q2 		– Sell
-14,000
Closed -$228K – 1377
2017
Q1 		$228K Sell
14,000
-1,300
-8% -$18.8K ﹤0.01% 1356
2016
Q4 		$231K Buy
15,300
+1,100
+8% +$15.5K ﹤0.01% 1325
2016
Q3 		$216K Buy
+14,200
New +$574K ﹤0.01% 1355

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

TD Asset Management's ITCI Position: Q1 2024 in Review

TD Asset Management sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2024, closing a stake of 72,648 shares — an estimated $5.2M sold.

TD Asset Management first reported a position in ITCI in Q3 2016 and held it in 14 quarters. The position peaked at $5.2M in Q4 2023. 345 funds tracked by Wall St. Rank hold ITCI as of Q1 2024.

  • TD Asset Management reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2024 after selling out during the quarter.
  • TD Asset Management sold 72,648 Intra-Cellular Therapies Inc. shares in Q1 2024, an estimated $5.2M.
  • TD Asset Management first reported a position in Intra-Cellular Therapies Inc. in Q3 2016 and held it in 14 quarters.
  • TD Asset Management's Intra-Cellular Therapies Inc. position peaked at $5.2M in Q4 2023.
  • 345 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2024.

Based on TD Asset Management's 13F filing for Q1 2024, filed 8 May 2024.